Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (16)

2024

  1. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

2023

  1. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease

    Frontiers in Immunology, Vol. 14

  2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

2019

  1. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 1, pp. 359-368

2016

  1. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation

    Transplantation Proceedings

2014

  1. Informe del Taller Ibérico de Histocompatibilidad 2013. Componente de análisis de situación de procedimiento de pruebas cruzadas en guardias de trasplante de órganos

    Inmunologia, Vol. 33, Núm. 1, pp. 27-33

2013

  1. Taller de Autoinmunidad 2013 de la Sociedad Española de Inmunología. Anticuerpos anticitoplasma de neutrófilo (ANCA)

    Inmunologia, Vol. 32, Núm. 4, pp. 148-156

2012

  1. Informe del Taller Ibérico de Histocompatibilidad 2012. Componente de estandarización de resultados de anticuerpos anti-HLA mediante ensayo en fase sólida

    Inmunologia

2008

  1. Gly111Ser mutation in CD8A gene causing CD8 immunodeficiency is found in Spanish Gypsies

    Molecular Immunology, Vol. 45, Núm. 2, pp. 479-484

2004

  1. Therapeutic immunization with an inactivated HIV-1 Immunogen plus antiretrovirals versus antiretroviral therapy alone in asymptomatic HIV-infected subjects

    Vaccine, Vol. 22, Núm. 23-24, pp. 2966-2973

1994

  1. HLA CLASS II AND SUSCEPTIBILITY AND RESISTANCE TO INSULIN‐DEPENDENT DIABETES MELLITUS IN A POPULATION FROM THE NORTHWEST OF SPAIN

    International Journal of Immunogenetics, Vol. 21, Núm. 4, pp. 219-229

1993

  1. Specific DQB1 sequences from DR13/Dw18 (DQB1*0603) and DR13/Dw19 (DQB1*0604) haplotypes can confer resistance to multiple sclerosis

    Inmunologia, Vol. 12, Núm. 1, pp. 26-30

  2. The germline repertoire of T cell receptor β-chain genes in multiple sclerosis patients from Spain

    Journal of Neuroimmunology, Vol. 47, Núm. 1, pp. 9-13

1992

  1. Molecular typing of HLA-B27 alleles

    Immunogenetics, Vol. 36, Núm. 5, pp. 277-282

1991

  1. Mspl RFLP of the human TCR gamma chain variable gene V9 (TCRGV9)

    Nucleic Acids Research, Vol. 19, Núm. 20, pp. 5806